Page last updated: 2024-08-22

tiletamine hydrochloride and Cardiovascular Stroke

tiletamine hydrochloride has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dacso, CC; Gaber, MW; Kim, JH; Leach, JP; Lonard, DM; Martin, JF; Monroe, TO; Mullany, LK; O'Malley, BW; Ortiz, AR; Rohira, AD; Rosengart, TK; Sarkar, P; Sikora, AG; Song, Y; Stork, B; York, B	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Cardiovascular Stroke

Article	Year
A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Cell Differentiation; Cyclohexanones; Fibroblasts; Fibrosis; Heart Function Tests; Inflammation; Macrophages; Mice; Myocardial Infarction; Pyridines; RAW 264.7 Cells; Receptors, Steroid; RNA; Transcription, Genetic; Ventricular Remodeling	2020

Article

Year

A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction.

Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

Topics: Animals; Cell Differentiation; Cyclohexanones; Fibroblasts; Fibrosis; Heart Function Tests; Inflammation; Macrophages; Mice; Myocardial Infarction; Pyridines; RAW 264.7 Cells; Receptors, Steroid; RNA; Transcription, Genetic; Ventricular Remodeling

2020